Stand Up To Cancer - standuptocancer.orgThis is where the end of cancer begins
   Please leave this field empty

SU2C Scientific Research Teams

Share this:

Like this page on Facebook

Gerrit A. Meijer, MD, PhD

Scientific Research Team:
Gerrit A. Meijer, MD, PhD

Gerrit A. Meijer, MD, PhD

Gerrit Meijer is professor of pathology with a special interest in translational cancer research, focusing on the gastrointestinal tract. The work of his research group involves DNA-, RNA-, and protein-based tumor profiling using “-omics” techniques, in order to stratify patient groups and arrive at individually tailored therapies, as well as for biomarker development to improve colorectal cancer screening. In addition, he is involved in several national and international research infrastructure programs including CTMM TraIT, EATRIS, BBMRI, and the tranSMART foundation.

Dr. Meijer obtained his medical degree in 1993 and his doctorate in 1997, both from VU University in Amsterdam, and he was registered as a pathologist in 2000. He was appointed professor of gastrointestinal pathology in 2004, and he became chair of the Department of Pathology in 2009. Meijer joined the Netherlands Cancer Institute in 2015 as head of pathology. He has published more than 250 papers in peer-reviewed journals. Meijer chairs the scientific council of the Dutch Cancer Society. Since 2013 he has been national co-director of the European Infrastructure for Translational Medicine (EATRIS).